Johnson & Johnson met EPS expectations, but was short on revenue and cut its full-year guidance, sending the shares down in premarket trading.
Excluding items, the health-care products giant posted 1.21 in earnings per share, matching the Street’s view. But its $15.33 billion in revenue fell short of the $15.64 billion that Wall Street was expecting. Johnson & Johnson lowered its earnings guidance to to $4.65 to $4.75 per share. In its last earnings report it pegged full year guidance at $4.80 to $4.90 per share.
No comments:
Post a Comment